当前位置:
X-MOL 学术
›
Nat. Rev. Clin. Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Two decades of advances in clinical oncology — lessons learned and future directions
Nature Reviews Clinical Oncology ( IF 81.1 ) Pub Date : 2024-10-01 , DOI: 10.1038/s41571-024-00945-4 Susana Banerjee, Christopher M. Booth, Eduardo Bruera, Markus W. Büchler, Alexander Drilon, Terry J. Fry, Irene M. Ghobrial, Luca Gianni, Rakesh K. Jain, Guido Kroemer, Josep M. Llovet, Georgina V. Long, Klaus Pantel, Kathy Pritchard-Jones, Howard I. Scher, Josep Tabernero, Ralph R. Weichselbaum, Michael Weller, Yi-Long Wu
Nature Reviews Clinical Oncology ( IF 81.1 ) Pub Date : 2024-10-01 , DOI: 10.1038/s41571-024-00945-4 Susana Banerjee, Christopher M. Booth, Eduardo Bruera, Markus W. Büchler, Alexander Drilon, Terry J. Fry, Irene M. Ghobrial, Luca Gianni, Rakesh K. Jain, Guido Kroemer, Josep M. Llovet, Georgina V. Long, Klaus Pantel, Kathy Pritchard-Jones, Howard I. Scher, Josep Tabernero, Ralph R. Weichselbaum, Michael Weller, Yi-Long Wu
Since the publication of the first issue of Nature Reviews Clinical Oncology, we have witnessed advances in multiple research areas that have culminated in improved outcomes for many cancer types, although substantial unmet needs remain for a majority of patients worldwide. Here, we have asked experts in several key specialities to reflect on the progress from the past 20 years and propose the next steps to enable further advances. Although we are aware that this Viewpoint cannot provide full coverage of the vast field that is clinical oncology, we hope that these messages inspire a diverse range of readers.
中文翻译:
临床肿瘤学二十年的进步 — 经验教训和未来方向
自第一期 Nature Reviews Clinical Oncology 出版以来,我们见证了多个研究领域的进步,这些进步最终改善了许多癌症类型的结果,尽管全球大多数患者仍有大量未满足的需求。在这里,我们邀请了几个关键专业的专家来反思过去 20 年的进展,并提出下一步行动以实现进一步进步。尽管我们知道本《观点》无法全面涵盖临床肿瘤学这一广阔的领域,但我们希望这些信息能激发不同的读者。
更新日期:2024-10-02
中文翻译:
临床肿瘤学二十年的进步 — 经验教训和未来方向
自第一期 Nature Reviews Clinical Oncology 出版以来,我们见证了多个研究领域的进步,这些进步最终改善了许多癌症类型的结果,尽管全球大多数患者仍有大量未满足的需求。在这里,我们邀请了几个关键专业的专家来反思过去 20 年的进展,并提出下一步行动以实现进一步进步。尽管我们知道本《观点》无法全面涵盖临床肿瘤学这一广阔的领域,但我们希望这些信息能激发不同的读者。